Skip to main content
. 2008 Nov 18;12(6):R143. doi: 10.1186/cc7121

Table 2.

Hemodynamic variables of study patients

Baseline 12 hours P value
Pulmonary artery occlusion pressure (mmHg) 1.000
 Phenylephrine 15 ± 2 17 ± 3*
 Norepinephrine 15 ± 2 17 ± 3*
Right atrial pressure (mmHg) 0.902
 Phenylephrine 13 ± 3 15 ± 3*
 Norepinephrine 13 ± 3 14 ± 3*
Mean pulmonary arterial pressure (mmHg) 0.521
 Phenylephrine 28 ± 9 33 ± 11*
 Norepinephrine 27 ± 5 30 ± 4*
Pulmonary vascular resistance index (dyne·s/cm5/m2) 0.330
 Phenylephrine 293 ± 253 348 ± 296*
 Norepinephrine 235 ± 103 264 ± 105
Right ventricular stroke work index (g/m2/beat) 0.564
 Phenylephrine 9 ± 5 12 ± 7*
 Norepinephrine 8 ± 4 11 ± 4*
Left ventricular stroke work index (g/m2/beat) 0.721
 Phenylephrine 25 ± 11 35 ± 14*
 Norepinephrine 25 ± 8 37 ± 9*
Stroke volume index (g/m2/beat) 0.963
 Phenylephrine 45 ± 18 49 ± 19
 Norepinephrine 46 ± 13 50 ± 11
Cardiac troponin I (ng/ml) 0.854
 Phenylephrine 1.0 ± 0.9 1.1 ± 0.9
 Norepinephrine 0.9 ± 0.9 1.1 ± 0.8

*P < 0.05 versus baseline (significant time effect).

HHS Vulnerability Disclosure